Advertisement

Drugs & Therapy Perspectives

, Volume 23, Issue 4, pp 14–17 | Cite as

Management of diabetic foot depends on the stage of the disease and the underlying pathology

Disease Management
  • 21 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. In: Bowker JH, Pfeifer MA, editors. Levin and O’Neal’s the diabetic foot. 6th ed. St Louis (MO): Mosby, 2001: 13–32Google Scholar
  2. 2.
    Jude EB, Unsworth PF. Optimal treatment of infected diabetic foot ulcers. Drugs Aging 2004; 21(13): 833–850PubMedCrossRefGoogle Scholar
  3. 3.
    Driver VR, Madsen J, Goodman RA. Reducing amputation rates in patients with diabetes at a military medical center: the limb preservation service model. Diabetes Care 2005 Feb; 28(2): 248–53PubMedCrossRefGoogle Scholar
  4. 4.
    Edmonds M, Foster AVM. Reduction of major amputations in the diabetic ischemic foot: a strategy to ‘take control’ with conservative care as well as revascularisation. Vasa 2001; 58 Suppl.: 6–14CrossRefGoogle Scholar
  5. 5.
    Edmonds M. Diabetic foot ulcers: practical treatment recommendations. Drugs 2006; 66(7): 913–29PubMedCrossRefGoogle Scholar
  6. 6.
    Edmonds M, Foster AVM, Sanders LJ. A practical manual of diabetic foot care. Oxford: Blackwell Science, 2004CrossRefGoogle Scholar
  7. 7.
    Hutchinson A, McIntosh A, Feder G, et al. Clinical guidelines and evidence review for type 2 diabetes: prevention and management of foot problems. London: Royal College of General Practitioners, 2000 AprGoogle Scholar
  8. 8.
    Peters FJG, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001; 24: 1442–7PubMedCrossRefGoogle Scholar
  9. 9.
    Sanders LJ, Frykberg RG. Charcot neuroarthropathy of the foot. In: Bowker JH, Pfeifer MA, editors. Levin and O’Neal’s the diabetic foot. 6th ed. St Louis (MO): Mosby, 2000: 467–482Google Scholar
  10. 10.
    Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001 Nov; 44(11): 2032–7PubMedCrossRefGoogle Scholar
  11. 11.
    Boulton AJ. The diabetic foot: from art to science: the 18th Camillo Golgi lecture. Diabetologia; 2004 Aug; 47(8): 1343–53PubMedCrossRefGoogle Scholar
  12. 12.
    Armstrong DG, Nguyen HC, Lavery LA, et al. Off loading the diabetic foot wound. Diabetes Care 2001; 24: 1019–22PubMedCrossRefGoogle Scholar
  13. 13.
    Cavanagh PR, Lipsky BA, Bradbury AW, et al. Treatment for diabetic foot ulcers. Lancet 2005 Nov 12; 366(9498): 1725–35PubMedCrossRefGoogle Scholar
  14. 14.
    Edmonds ME, Foster AVM. Managing the diabetic foot. Oxford: Blackwell Science, 2005Google Scholar
  15. 15.
    Edmonds ME, Walters H. Angioplasty and the diabetic foot. Vasc Med Rev 1995; 6: 205–14Google Scholar
  16. 16.
    Tentolouris N, Petrikkos G, Vallianou N, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. N Clin Microbiol Infect 2006 Feb; 12(2): 186–9CrossRefGoogle Scholar
  17. 17.
    Senneville E, Melliez H, Beltrand E, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis; 2006 Jan 1; 42(1): 57–62PubMedCrossRefGoogle Scholar
  18. 18.
    Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis; 2004 Oct 1; 39(7): 885–910PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Personalised recommendations